CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-28 | Meredith Ian T EVP Global Chief Med Officer | Sale | −6,588 | $43.68 | $288K | 28,082 |
| 2022-02-28 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,019 | 34,970 | ||
| 2022-02-28 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −300 | $44.17 | $13K | 34,670 |
| 2022-02-28 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion · Deferred Stock Units | −1,019 | 0 | ||
| 2022-02-22 | Meredith Ian T EVP Global Chief Med Officer | Grant or award · Performance Share Units | +6,540 | 6,540 | ||
| 2022-02-21 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,013 | 34,249 | ||
| 2022-02-21 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −298 | $42.55 | $13K | 33,951 |
| 2022-02-21 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion · Deferred Stock Units | −1,013 | 1,013 | ||
| 2022-02-18 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,037 | 33,541 | ||
| 2022-02-18 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −305 | $42.55 | $13K | 33,236 |
| 2022-02-18 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion · Deferred Stock Units | −1,037 | 2,076 | ||
| 2022-02-17 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,250 | 32,871 | ||
| 2022-02-17 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −367 | $42.83 | $16K | 32,504 |
| 2022-02-17 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion · Restricted Stock Units | −1,250 | 3,750 | ||
| 2022-02-16 | Meredith Ian T EVP Global Chief Med Officer | Grant or award · Restricted Stock Units | +4,525 | 4,525 | ||
| 2022-02-16 | Meredith Ian T EVP Global Chief Med Officer | Grant or award · Stock Option (Right to Buy) | +12,941 | 12,941 | ||
| 2022-02-15 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,108 | 31,947 | ||
| 2022-02-15 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −326 | $44.01 | $14K | 31,621 |
| 2022-02-15 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion · Deferred Stock Units | −1,108 | 1,108 | ||
| 2022-02-01 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +3,131 | 31,758 |
Page 1 of 2 · 26 trades